TransMedics Group, Inc.
(TMDX - NASDAQ)
108,30 USD
📋 Profilo Aziendale

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.

|